Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for aids
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on aids or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on aids and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
Osteoporosis Decision Aid Osteoporosis Decision Aid | Mayo Clinic Shared Decision Making National Resource Center Toggle navigation Osteoporosis Decision Aid The Osteoporosis Choice decision aid conveys the pros and cons of treatment It uses estimates of the patient's based on the FRAX calculator. Decision aids to be used during the encounter: interactive tool Printed version Decision aids in practice: Additional resources DISCLAIMER : No decision aid replaces the conversation patients should (...) have with their clinicians to make important, clinical decisions. Use of these decision aids carries no liability to its developers or to the Mayo Clinic Foundation for Education and Research. Feedback If you download our decision aids, we would love to hear from you! Please send us a note at to let us know who you are, why you are interested in the decision aid(s), and how you plan to use them. Remember to check back to this page periodically to make sure you are using the most up-to-date version
Invitation and decision aid for bowel cancer screening Einladungsschreiben und Entscheidungshilfen zum Darmkrebs-Screening; Abschlussbericht; Auftrag P15-01 [Invitation and decision aid for bowel cancer screening] Einladungsschreiben und Entscheidungshilfen zum Darmkrebs-Screening; Abschlussbericht; Auftrag P15-01 [Invitation and decision aid for bowel cancer screening] Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen Record Status This is a bibliographic record of a published (...) health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Einladungsschreiben und Entscheidungshilfen zum Darmkrebs-Screening; Abschlussbericht; Auftrag P15-01. [Invitation and decision aid for bowel cancer screening] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 451. 2016 Final publication URL
IM AIDS Vaccines AcquiredImmunodeficiencySyndrome epidemiology history prevention & control Anti-Retroviral Agents administration & dosage adverse effects history CD4 Lymphocyte Count Drug Administration Schedule Drug Therapy, Combination HIV Infections drug therapy epidemiology history History, 20th Century History, 21st Century Humans Pandemics 2015 12 2 6 0 2015 12 2 6 0 2015 12 23 6 0 ppublish 26624554 10.1056/NEJMp1502020 (...) Ending the HIV-AIDS Pandemic - Follow the Science. 26624554 2015 12 22 2015 12 03 1533-4406 373 23 2015 Dec 03 The New England journal of medicine N. Engl. J. Med. Ending the HIV-AIDS Pandemic--Follow the Science. 2197-9 10.1056/NEJMp1502020 Fauci Anthony S AS From the National Institute of Allergy and Infectious Diseases, Bethesda, MD. Marston Hilary D HD eng Historical Article Journal Article 2015 12 01 United States N Engl J Med 0255562 0028-4793 0 AIDS Vaccines 0 Anti-Retroviral Agents AIM
Decision aids for people considering taking part in clinical trials. Several interventions have been developed to promote informed consent for participants in clinical trials. However, many of these interventions focus on the content and structure of information (e.g. enhanced information or changes to the presentation format) rather than the process of decision making. Patient decision aids support a decision making process about medical options. Decision aids support the decision process (...) by providing information about available options and their associated outcomes, alongside information that enables patients to consider what value they place on particular outcomes, and provide structured guidance on steps of decision making. They have been shown to be effective for treatment and screening decisions but evidence on their effectiveness in the context of informed consent for clinical trials has not been synthesised.To assess the effectiveness of decision aids for clinical trial informed
Decision aids for breast cancer surgery: a randomised controlled trial. 25647821 2015 09 28 2016 10 20 1024-2708 20 Suppl 7 2014 Dec Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Decision aids for breast cancer surgery: a randomised controlled trial. 24-7 Lam W W T WW Department of Community Medicine, School of Public Health, The University of Hong Kong. Fielding R R Department of Community Medicine, School of Public Health, The University of Hong Kong. Butow P P School
How much donor financing for health is channelled to global versus country-specific aid functions? The slow global response to the Ebola crisis in west Africa suggests that important gaps exist in donor financing for key global functions, such as support for health research and development for diseases of poverty and strengthening of outbreak preparedness. In this Health Policy, we use the International Development Statistics databases to quantify donor support for such functions. We classify (...) donor funding for health into aid for global functions (provision of global public goods, management of cross-border externalities, and fostering of leadership and stewardship) versus country-specific aid. We use a new measure of donor funding that combines official development assistance (ODA) for health with additional donor spending on research and development (R&D) for diseases of poverty. Much R&D spending falls outside ODA--ie, the assistance that is conventionally reported through ODA
Decision Aid for Cigarette Smokers Scheduled for Elective Surgery Decision aids can increase patient involvement in decision-making about health care. The study goal was to develop and test a decision aid for use by clinicians in discussion options for changing smoking behavior before and after elective surgery.In formative work, a decision aid was designed to facilitate patient-clinician discussion regarding three options: continue smoking, attempt a period of temporary abstinence, and attempt (...) to quit smoking for good. A randomized, two-group pilot study was then conducted in smokers evaluated in preparation for elective surgery in a preoperative clinic to test the hypothesis that the decision aid would improve measures of decisional quality compared with usual care.The final decision aid consisted of three laminated cards. The front of each card included a colorful graphic describing each choice; the reverse including two to three pros and cons for each decision, a simple graphic
Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid (...) survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation. Health Technology Assessment 2015; 19(32) Authors' objectives To develop an Aneurysm Repair Decision Aid (ARDA) to indicate when elective AAA repair optimises survival for individual patients and to assess the cost-effectiveness and associated uncertainty of elective repair at the aneurysm diameter recommended by the ARDA compared with current practice. Authors' conclusions The ARDA provides
Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation Journals Library An error occurred retrieving content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you
human cancer. Common non-random mutations comprise DNA strand-biased mutation showers and mutations restricted to certain DNA motifs, which recently have become attributed to the activity of the AID/APOBEC family of DNA deaminases. Hence, APOBEC enzymes, which have evolved as key players in natural and adaptive immunity, have been proposed to contribute to cancer development and clonal evolution of cancer by inducing collateral genomic damage due to their DNA deaminating activity. This review (...) AID/APOBEC deaminases and cancer Mutations are the basis for evolution and the development of genetic diseases. Especially in cancer, somatic mutations in oncogenes and tumor suppressor genes alongside the occurrence of passenger mutations have been observed by recent deep-sequencing approaches. While mutations have long been considered random events induced by DNA-replication errors or by DNA damaging agents, genome sequencing led to the discovery of non-random mutation signatures in many
The Addition of Platelet Rich Fibrin (PRF) to Open Flap Debridement (OFD) Aids in The Treatment of Chronic Periodontitis with Intrabony Defects UTCAT2905, Found CAT view, CRITICALLY APPRAISED TOPICs University: | | ORAL HEALTH EVIDENCE-BASED PRACTICE PROGRAM View the CAT / Title The Addition of Platelet Rich Fibrin (PRF) to Open Flap Debridement (OFD) Aids in The Treatment of Chronic Periodontitis with Intrabony Defects Clinical Question In patients with chronic periodontitis, does the addition (...) of platelet-rich fibrin (PRF) to open flap debridement (OFD) aid in the resolution of intrabony defects (vertical alveolar bone loss)? Clinical Bottom Line Platelet-rich Fibrin (PRF) is obtained from a centrifuged blood sample taken from the patient. The addition of PRF to OFD aids in the treatment of chronic periodontitis in patients with intrabony defects by decreasing probing depths, raising clinical attachment levels, and displaying radiographic bone-fill. Best Evidence (you may view more info
Optical reading aids for children and young people with low vision. Low vision in childhood is a significant barrier to learning and development, particularly for reading and education. Optical low vision aids may be used to maximise the child's functional vision. The World Health Organization (WHO) has previously highlighted the importance of the use of low vision aids in managing children with visual impairment across the world.To assess the effect of optical low vision aids on reading (...) Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (www.who.int/ictrp/search/en). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 8 January 2015.We also used manual searching to check the references listed in retrieved articles. Manufacturers of low vision aids were contacted to request any information about studies or research regarding their products.We planned to include randomised
Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial. Mammography screening can reduce breast cancer mortality. However, most women are unaware that inconsequential disease can also be detected by screening, leading to overdiagnosis and overtreatment. We aimed to investigate whether including information about overdetection of breast cancer in a decision aid would help women aged around 50 years (...) to make an informed choice about breast screening.We did a community-based, parallel-group, randomised controlled trial in New South Wales, Australia, using a random cohort of women aged 48-50 years. Recruitment to the study was done by telephone; women were eligible if they had not had mammography in the past 2 years and did not have a personal or strong family history of breast cancer. With a computer program, we randomly assigned 879 participants to either the intervention decision aid (comprising
2015LancetControlled trial quality: predicted high
Decision aids for cancer screening and treatment Decision aids for cancer screening and treatment Decision aids for cancer screening and treatment Trikalinos TA, Wieland LS, Adam GP, Zgodic A, Ntzani EE Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Trikalinos TA, Wieland LS, Adam GP, Zgodic A, Ntzani EE. Decision aids for cancer (...) screening and treatment. Rockville: Agency for Healthcare Research and Quality (AHRQ). Comparative Effectiveness Review No. 145. 2014 Authors' objectives We sought to appraise and synthesize the evidence assessing the effectiveness of decision aids targeting health care consumers who face decisions about cancer screening or prevention, or early cancer treatment (Key Question 1), particularly with regard to decision aid or patient characteristics that might function as effect modifiers. We also reviewed
Rapid point of care combined Antigen/Antibody HIV test to aid in the diagnosis of HIV infection 1 Public Summary Document Application No. 1391 – Rapid point-of-care combined Antigen/Antibody HIV test to aid in the diagnosis of HIV infection Applicant: ANZPI, Alere Pty Ltd Date of MSAC consideration: MSAC 64 th Meeting, 30-31 July 2015 Context for decision: MSAC makes its advice in accordance with its Terms of Reference, see at www.msac.gov.au. 1. Purpose of application and links to other (...) applications An application was submitted by Inverness Medical Innovations Australia Pty Ltd for MBS listing of a rapid point-of-care combined Antigen/Antibody test for diagnosis of human immunodeficiency virus (HIV) infection for use in GP and sexual health clinics. The test for HIV infection is intended to be used in individuals where an HIV test is indicated and in those who are at high-risk of HIV infection. The evidence for assessment of this application was submitted in May 2015. 2. MSAC’s advice
Choosing how to birth your baby: A decision aid for women with a previous caesarean section Choosing how to birth your baby: A decision aid for women with a previous caesarean sectionThis decision aid has been written to support women who have had one or more previous caesareans, to know what to expect and have a say in making decisions about the way they would like to birth. This decision aid provides information about two options: 1 Choose to have a vaginal birth after caesarean (VBAC) 2 (...) Choose to have a planned repeat caesarean section This decision aid will answer the following questions: » What are my options when choosing to birth my baby after a previous caesarean section? » What happens if I choose to have a vaginal birth after caesarean? » What happens if I choose to have a planned repeat caesarean section? » Will I always be able to choose? » How might I choose between a VBAC and a planned repeat caesarean section? » What are the differences between having a VBAC and having